Clinical Trials Browser

Phase 1 × OTHER × IMC-001 × Clear all

NCT05393713 2025-12-03

Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study

Phase 1 Terminated

Melanoma